Le Lézard
Classified in: Health
Subjects: PDT, WOM, SCZ

SciLife Biosciences Set to Disrupt "Normal" Aging With Vitameretm


ARLINGTON, Texas, Jan. 30, 2018 /PRNewswire/ -- SciLife Biosciences announced today the introduction of a neutraceutical designed to combat the decline typically associated with aging: Vitameretm Anti-Aging Support.

Dr. Jacob Rosenstein, SciLife Biosciences principal investor and founder of the Southwest Age Intervention Institute, is also a board-certified neurosurgeon. He is on a mission to bring Vitamere Anti-Aging Support and his program for living a longer, healthier life to people everywhere.

According to Vitameretm Anti-Aging Support developer Dr. Jacob Rosenstein, the normal process by which the body's cells undergo aging and death is impacted by chronic inflammation and telomere length ? two key factors associated with age-related disease and decline.

Vitameretm Anti-Aging Support is specifically formulated to help optimize DNA and cellular health, with ingredients supported by the combined findings from 68 peer-reviewed scientific studies. Vitameretm Anti-Aging Support works at the cellular level, protecting and revitalizing telomeres ? the protective caps at both ends of the chromosomes ? to keep cells functioning and dividing normally.

A noted neurosurgeon and age management specialist, Dr. Rosenstein has distilled the results of decades of scientific research into a program for living longer ? to 100 and beyond ?  and healthier, with vigor and vitality. His customized regimen of nutritional supplementation, diet, and exercise is designed to reduce inflammation and increase telomere length, thus reducing biologic age.

Inspired by the remarkable results he has achieved treating patients at his Southwest Age Intervention Institute, Dr. Rosenstein has joined with SciLife as a principal investor and spokesperson to make Vitameretm Anti-Aging Support commercially available.  

"I want to help people take control of their health and live more vigorous, energetic, and productive lives," says Dr. Rosenstein. "I have been doing this one patient at a time. Now it's time to do it on a large scale. We need to get the message out that the rest of your life can be the best of your life."

About Vitameretm Anti-Aging Support

VITAMEREtm Anti-Aging Support was developed based on decades of physiologic research and current scientific understanding of the cellular aging process. To learn more about cellular health, longevity and age management, and to purchase VITAMEREtm products, visit http://www.scilifebiosciences.com/.

About SciLife Biosciences

SciLife Biosciences is a consortium of professionals dedicated to promoting longevity in combination with optimal health, increased energy and improved cognitive function. Representing years of training and expertise in the science of aging, medical research and clinical age management, the SciLife team translates the latest findings into precisely formulated nutritional supplements. For more information visit http://www.scilifebiosciences.com/.

About Dr. Rosenstein

Dr. Jacob Rosenstein is an author and speaker who is passionate about helping people get and stay well. He is a board-certified neurosurgeon and diplomate of the American Board of Neurological Surgery as well as a Fellow of the American College of Surgeons. Dr. Rosenstein is the founder of North Texas Neurosurgical Consultants and Southwest Age Intervention Institute in the Dallas/ Fort Worth Metroplex, and a principal at SciLife Biosciences. He has been in private practice since 1985 and specializes in Neurological Surgery and Age Management/Anti-Aging Medicine. The story of his own transformation from a declining middle age to youthful vigor and vitality has made him a feature online, on television and in print. He wrote and starred in The Dr. R Show, a TV series on health and wellness.

Contact:
John Cordone
SciLife Biosciences
350 Higby Road
Middletown, CT 06457
Email: [email protected]  
Phone: 203-676-6685

 

SOURCE SciLife Biosciences


These press releases may also interest you

at 01:00
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ?  Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...



News published on and distributed by: